New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2014
07:09 EDTALIMAlimera Sciences resubmits NDA for Iluvien
Alimera Sciences has resubmitted its New Drug Application for Iluvien to the FDA. At this time, Alimera awaits the FDA's acceptance of the resubmission and a Prescription Drug User Fee Act date.
News For ALIM From The Last 14 Days
Check below for free stories on ALIM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2014
16:13 EDTALIMAlimera receives marketing authorization in Denmark for treatment of DME
Subscribe for More Information
July 28, 2014
16:04 EDTALIMAlimera Sciences says NMEB grants marketing authorization to ILUVIEN
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use